Omada Health (OMDA)
$18.30-16.32%Close
BUYCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.1B
- Beta
- 2.02
- P/E (TTM)
- 269.51
- Short % float
- 163.11%
- Days to cover
- 4.4
- SI change
- -0.2%
- 1W
- -11.72%
- 1M
- -10.73%
- vs SPY 1W
- -11.58%
- vs SPY 1M
- -13.24%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 43
- VALUE
- 8
- GROWTH
- 42
- GARP
- 53
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC1.1%
REV YoY-
ROE1.8%
EPS YoY-
ROA1.3%
GROSS68
OP0
NET1
[VALUATION]
P/E TTM269.51
P/E FWD46.41
SECTOR PE20.34
INDUSTRY PE24.21
P/B4.32
P/FCF-
EV/EBITDA84.55
EV/EBIT-
PEG1.30
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO3.91
ND/EBITDA-
BETA2.02
Company news
FAQ
- What is LOPJLB’s current signal on OMDA?
- LOPJLB’s latest quantitative signal on Omada Health (OMDA) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is OMDA in?
- Omada Health (OMDA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Omada Health (OMDA) do?
- Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and we…